Bulletin
Investor Alert

TG Therapeutics Inc.

NAS: TGTX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209240121/composite

$

10.00

Change

+0.27 +2.77%

Volume

Volume 59,157

Jan 28, 2022, 7:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209240121/composite

Today's close

$ 8.27

$ 9.73

Change

+1.46 +17.65%

Day low

Day high

$8.28

$9.73

Open
Open: 8.46

52 week low

52 week high

$8.05

$56.50

Open

Market cap

$1.18B

Average volume

2.68M

P/E ratio

N/A

Rev. per Employee

$16,199

EPS

-2.64

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/tgtx

MarketWatch News on TGTX

  1. TG Therapeutics stock price target cut to $20 from $36 at Evercore ISI

    12:36 p.m. Jan. 27, 2022

    - Tomi Kilgore

  2. TG Therapeutics stock price target cut to $49 from $63 at B. Riley

    7:35 a.m. Dec. 1, 2021

    - Tomi Kilgore

  3. 4 Beaten-Down Biotech Stocks That Could Take Off

    3:07 p.m. Nov. 17, 2021

    - Barron's Online

  4. 4 Midsize Biotech Stocks That Have Breakout Potential

    9:02 a.m. Sept. 23, 2021

    - Barron's Online

  5. TG Therapeutics stock price target cut to $63 from $91 at B. Riley

    6:57 a.m. Aug. 3, 2021

    - Tomi Kilgore

  6. 4 Biotech Stocks That Could Be Bargains

    7:08 a.m. July 22, 2021

    - Barron's Online

  7. Biotech M&A Has Been Slow This Year. Why It Might Get Busier.

    7:32 a.m. May 21, 2021

    - Barron's Online

  8. TG Therapeutics started at overweight with $38 stock price target at J.P. Morgan

    6:39 a.m. Sept. 1, 2020

    - Tomi Kilgore

  9. TG Therapeutics stock price target raised to $44 from $39 at Ladenburg Thalmann

    7:12 a.m. May 12, 2020

    - Tomi Kilgore

  10. TG Therapeutics stock price target raised to $25 from $17 at B. Riley FBR

    7:49 a.m. Jan. 17, 2020

    - Tomi Kilgore

  11. Harry Boxer’s three stocks breaking out on earnings news

    11:23 a.m. Feb. 7, 2018

    - Harry Boxer

  12. Healthcare Stocks: Calm After The Storm?

    10:16 a.m. Aug. 1, 2017

    - Barrons Blogs

  13. TG Therapeutics stock rises 17% on positive late-stage cancer trial results

    6:58 a.m. June 5, 2017

    - Emma Court

  14. Harry Boxer’s two infrastructure stocks to watch

    2:23 p.m. April 26, 2017

    - Harry Boxer

  15. TG Therapeutics stock rises 2% on preclinical data for anti-PD-L1 monoclonal antibody

    12:10 p.m. April 4, 2017

    - Emma Court

  16. Charting the Market

    12:35 a.m. March 11, 2017

    - Barron's Online

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/tgtx

Other News on TGTX

  1. TG Therapeutics: Double Down On Partial Clinical Hold Non-Issue

    2:51 p.m. Today

    - Seeking Alpha

  2. TG Therapeutics rebounds as B. Riley defends after selloff

    11:13 a.m. Today

    - Seeking Alpha

  3. PIXY, MARPS and INDO among mid-day movers

    12:51 p.m. Jan. 27, 2022

    - Seeking Alpha

  4. The State Of Biotech In 2022

    4:04 a.m. Jan. 3, 2022

    - Seeking Alpha

  5. TG Therapeutics: Elucidating The Upcoming Binary Event

    8:18 p.m. Dec. 26, 2021

    - Seeking Alpha

  6. IBB And XBI: 4 Reasons To Buy Biotech Stocks Ahead Of 2022

    8:33 a.m. Dec. 6, 2021

    - Seeking Alpha

  7. TG Therapeutics Debacle: I Am Doubling Down

    4:46 a.m. Dec. 5, 2021

    - Seeking Alpha

  8. MCRB, DADA and ATXI among mid-day movers

    1:18 p.m. Nov. 30, 2021

    - Seeking Alpha

  9. Why TG Therapeutics Is Plunging More Than 40% Today

    12:41 p.m. Nov. 30, 2021

    - Motley Fool

  10. Warning: TGTX is at high risk of performing badly

    4:45 a.m. Nov. 24, 2021

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/tgtx

Press Releases on TGTX

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.